LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 9 of total 9

Search options

  1. Article ; Online: Sars-CoV-2: A clinical update - II.

    Cespedes, Mateus da Silveira / Souza, José Carlos Rosa Pires de

    Revista da Associacao Medica Brasileira (1992)

    2020  Volume 66, Issue 4, Page(s) 547–557

    Abstract: Introduction: A covid-19 pandemic decreed by WHO has raised greater awareness of it.: Epidemiology: The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age.: ... ...

    Abstract Introduction: A covid-19 pandemic decreed by WHO has raised greater awareness of it.
    Epidemiology: The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age.
    Transmissibility: The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates.
    Physiopathology: The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa.
    Clinical manifestations: a presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2%.
    Diagnosis: allows the detection of viral load in CRP-TR of patients with high clinical suspicion.
    Treatment: based on supportive measures and infection control. In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising. Take care to avoid the use of corticosteroids. There are no restrictions on the use of resources and IECAs / BRAs.
    MeSH term(s) Angiotensin-Converting Enzyme 2 ; Basic Reproduction Number ; Betacoronavirus ; COVID-19 ; Child ; Coronavirus Infections/diagnosis ; Coronavirus Infections/mortality ; Coronavirus Infections/physiopathology ; Coronavirus Infections/therapy ; Diagnosis, Differential ; Drug Therapy, Combination ; Humans ; Palliative Care/methods ; Pandemics ; Peptidyl-Dipeptidase A/metabolism ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/mortality ; Pneumonia, Viral/physiopathology ; Pneumonia, Viral/therapy ; SARS-CoV-2
    Chemical Substances Peptidyl-Dipeptidase A (EC 3.4.15.1) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Keywords covid19
    Language English
    Publishing date 2020-06-22
    Publishing country Brazil
    Document type Journal Article ; Review
    ZDB-ID 731969-1
    ISSN 1806-9282 ; 0104-4230 ; 0004-5241 ; 0102-843X
    ISSN (online) 1806-9282
    ISSN 0104-4230 ; 0004-5241 ; 0102-843X
    DOI 10.1590/1806-9282.66.4.547
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Coronavirus: a clinical update of Covid-19.

    Cespedes, Mateus da Silveira / Souza, José Carlos Rosa Pires de

    Revista da Associacao Medica Brasileira (1992)

    2020  Volume 66, Issue 2, Page(s) 116–123

    Abstract: A covid-19 pandemic decreed by WHO has raised greater awareness of it. The infection reached the mark of 350,000 patients in 33 countries and affected as comorbidities the presence of comorbidities and advanced age. The transmissibility calculated so far ...

    Abstract A covid-19 pandemic decreed by WHO has raised greater awareness of it. The infection reached the mark of 350,000 patients in 33 countries and affected as comorbidities the presence of comorbidities and advanced age. The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates. The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa. A presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2%.allows the detection of viral load in CRP-TR of patients with high clinical suspicion. Based on supportive measures and infection control. In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising. Take care to avoid the use of corticosteroids. There are no restrictions on the use of resources and ACEIs / ARBs.
    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections/diagnosis ; Coronavirus Infections/epidemiology ; Coronavirus Infections/therapy ; Coronavirus Infections/transmission ; Diagnosis, Differential ; Humans ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/therapy ; Pneumonia, Viral/transmission ; Risk Factors ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-05-15
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 731969-1
    ISSN 1806-9282 ; 0104-4230 ; 0004-5241 ; 0102-843X
    ISSN (online) 1806-9282
    ISSN 0104-4230 ; 0004-5241 ; 0102-843X
    DOI 10.1590/1806-9282.66.2.116
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Sars-CoV-2

    Mateus da Silveira Cespedes / José Carlos Rosa Pires de Souza

    Revista da Associação Médica Brasileira, Vol 66, Iss 4, Pp 547-

    A clinical update - II

    2020  Volume 557

    Abstract: SUMMARY INTRODUCTION A covid-19 pandemic decreed by WHO has raised greater awareness of it. EPIDEMIOLOGY The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age. ... ...

    Abstract SUMMARY INTRODUCTION A covid-19 pandemic decreed by WHO has raised greater awareness of it. EPIDEMIOLOGY The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age. TRANSMISSIBILITY The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates. PHYSIOPATHOLOGY The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa. CLINICAL MANIFESTATIONS a presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2%. DIAGNOSIS allows the detection of viral load in CRP-TR of patients with high clinical suspicion. TREATMENT based on supportive measures and infection control. In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising. Take care to avoid the use of corticosteroids. There are no restrictions on the use of resources and IECAs / BRAs.
    Keywords Public health ; Coronavirus ; COVID-19 ; Pandemics ; Respiratory tract infections ; Review ; Medicine (General) ; R5-920
    Subject code 610
    Language English
    Publishing date 2020-06-01T00:00:00Z
    Publisher Associação Médica Brasileira
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Coronavirus

    Cespedes, Mateus da Silveira / Souza, José Carlos Rosa Pires de

    Revista da Associação Médica Brasileira v.66 n.2 2020

    a clinical update of Covid-19

    2020  

    Abstract: SUMMARY INTRODUCTION A covid-19 pandemic decreed by WHO has raised greater awareness of it. EPIDEMIOLOGY The infection reached the mark of 350,000 patients in 33 countries and affected as comorbidities the presence of comorbidities and advanced age. ... ...

    Abstract SUMMARY INTRODUCTION A covid-19 pandemic decreed by WHO has raised greater awareness of it. EPIDEMIOLOGY The infection reached the mark of 350,000 patients in 33 countries and affected as comorbidities the presence of comorbidities and advanced age. TRANSMISSIBILITY The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates. PHYSIOPATHOLOGY The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa. CLINICAL MANIFESTATIONS a presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2%. DIAGNOSIS allows the detection of viral load in CRP-TR of patients with high clinical suspicion. TREATMENT based on supportive measures and infection control. In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising. Take care to avoid the use of corticosteroids. There are no restrictions on the use of resources and ACEIs / ARBs.
    Keywords coronavirus ; covid-19 ; SARS-CoV-2 ; pandemic ; update ; covid19
    Subject code 610
    Language English
    Publishing date 2020-02-01
    Publisher Associação Médica Brasileira
    Publishing country br
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Sars-CoV-2

    Cespedes, Mateus da Silveira / Souza, José Carlos Rosa Pires de

    Revista da Associação Médica Brasileira v.66 n.4 2020

    A clinical update - II

    2020  

    Abstract: SUMMARY INTRODUCTION A covid-19 pandemic decreed by WHO has raised greater awareness of it. EPIDEMIOLOGY The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age. ... ...

    Abstract SUMMARY INTRODUCTION A covid-19 pandemic decreed by WHO has raised greater awareness of it. EPIDEMIOLOGY The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age. TRANSMISSIBILITY The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates. PHYSIOPATHOLOGY The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa. CLINICAL MANIFESTATIONS a presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2%. DIAGNOSIS allows the detection of viral load in CRP-TR of patients with high clinical suspicion. TREATMENT based on supportive measures and infection control. In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising. Take care to avoid the use of corticosteroids. There are no restrictions on the use of resources and IECAs / BRAs.
    Keywords Public health ; Coronavirus ; COVID-19 ; Pandemics ; Respiratory tract infections ; Review ; covid19
    Subject code 610
    Language English
    Publishing date 2020-04-01
    Publisher Associação Médica Brasileira
    Publishing country br
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article: Sars-CoV-2: A clinical update - II

    Cespedes, Mateus da Silveira / Souza, Jose Carlos Rosa Pires de

    Revista da Associacao Medica Brasileira (1992)

    Abstract: INTRODUCTION: A covid-19 pandemic decreed by WHO has raised greater awareness of it EPIDEMIOLOGY: The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age TRANSMISSIBILITY: ...

    Abstract INTRODUCTION: A covid-19 pandemic decreed by WHO has raised greater awareness of it EPIDEMIOLOGY: The infection, reached the mark of 2,000,000 patients in 33 countries and caused the risk of the presence of comorbidities and advanced age TRANSMISSIBILITY: The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates PHYSIOPATHOLOGY: The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa CLINICAL MANIFESTATIONS: a presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2% DIAGNOSIS: allows the detection of viral load in CRP-TR of patients with high clinical suspicion TREATMENT: based on supportive measures and infection control In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising Take care to avoid the use of corticosteroids There are no restrictions on the use of resources and IECAs / BRAs
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #613693
    Database COVID19

    Kategorien

  7. Article: Coronavirus: a clinical update of Covid-19

    Cespedes, Mateus da Silveira / Souza, José Carlos Rosa Pires de

    Rev Assoc Med Bras (1992)

    Abstract: A covid-19 pandemic decreed by WHO has raised greater awareness of it. The infection reached the mark of 350,000 patients in 33 countries and affected as comorbidities the presence of comorbidities and advanced age. The transmissibility calculated so far ...

    Abstract A covid-19 pandemic decreed by WHO has raised greater awareness of it. The infection reached the mark of 350,000 patients in 33 countries and affected as comorbidities the presence of comorbidities and advanced age. The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates. The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa. A presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2%.allows the detection of viral load in CRP-TR of patients with high clinical suspicion. Based on supportive measures and infection control. In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising. Take care to avoid the use of corticosteroids. There are no restrictions on the use of resources and ACEIs / ARBs.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32428144
    Database COVID19

    Kategorien

  8. Article ; Online: Empatia e reconhecimento de expressões faciais de emoções básicas e complexas, em estudantes de Medicina da Universidade Estadual de Mato Grosso do Sul

    Amanda Magon / Lucas Rasi Cunha Leite / Mateus da Silveira Cespedes / José Carlos Rosa Pires de Souza

    Research, Society and Development, Vol 9, Iss

    2020  Volume 9

    Abstract: Objetivo: Avaliar a empatia e o processo humanístico na relação paciente-estudantes de medicina, sendo estes, acadêmicos do primeiro ao quarto ano do curso de Medicina da Universidade Estadual de Mato Grosso do Sul (UEMS). Métodos: O estudo, realizado de ...

    Abstract Objetivo: Avaliar a empatia e o processo humanístico na relação paciente-estudantes de medicina, sendo estes, acadêmicos do primeiro ao quarto ano do curso de Medicina da Universidade Estadual de Mato Grosso do Sul (UEMS). Métodos: O estudo, realizado de modo quantitativo, observacional e transversal, analisou 84 acadêmicos voluntários de medicina, do 1º ao 4º ano, por meio de questionários aplicados (Escala Jefferson, dados sociodemográficos e Read mind in the eyes). Os dados foram tabulados via Excel 2010 e analisados por meio do teste t-student com 95% de confiabilidade para as três escalas. Resultados: 84 acadêmicos aceitaram participar voluntariamente da pesquisa, preenchendo adequadamente ao TCLE e aos questionários. Dessa amostra, 21,43% pertenciam ao primeiro, 30,95%, ao segundo, 9,52% ao terceiro e 38,1% ao quarto anos. Em relação à Escala Jefferson de Empatia, a média foi de 84,59 pontos para o grupo do 1º ao 2º ano, e de 84,85 pontos para o grupo do 3º ao 4º ano; a média feminina (N = 43) foi de 83,91 pontos e a masculina (N = 41), de 85,56 pontos. No instrumento Read The Mind In The Eyes, a média feminina foi de 26,44 e a masculina, de 25,80. Em relação ao ano de faculdade, a média foi de 26,21 para o 1º e 2º anos, e de 26,05 para o 3º e 4º anos. Conclusão: Foi observado que o grau de empatia entre os acadêmicos do 1º ao 4º ano, bem como entre o sexo feminino e masculino, não foi estatisticamente significante.
    Keywords Empatia ; Expressão facial ; Emoções ; Estudantes ; Special aspects of education ; LC8-6691 ; Science (General) ; Q1-390 ; Social Sciences ; H
    Language English
    Publishing date 2020-09-01T00:00:00Z
    Publisher Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Coronavirus

    Mateus da Silveira Cespedes / José Carlos Rosa Pires de Souza

    Revista da Associação Médica Brasileira, Vol 66, Iss 2, Pp 116-123

    a clinical update of Covid-19

    Abstract: SUMMARY INTRODUCTION A covid-19 pandemic decreed by WHO has raised greater awareness of it. EPIDEMIOLOGY The infection reached the mark of 350,000 patients in 33 countries and affected as comorbidities the presence of comorbidities and advanced age. ... ...

    Abstract SUMMARY INTRODUCTION A covid-19 pandemic decreed by WHO has raised greater awareness of it. EPIDEMIOLOGY The infection reached the mark of 350,000 patients in 33 countries and affected as comorbidities the presence of comorbidities and advanced age. TRANSMISSIBILITY The transmissibility calculated so far is similar to the H1N1 epidemic, but with lower mortality rates. PHYSIOPATHOLOGY The SARS-CoV-2 virus, of the Coronaviridae family, has the capacity for cellular invasion through the angiotensin-converting enzyme 2 does not have a lower respiratory epithelium and in the cells of the small intestine mucosa. CLINICAL MANIFESTATIONS a presentation can be divided into mild (fever, fatigue, cough, myalgia, and sputum) and severe (cyanosis, dyspnoea, tachypnea, chest pain, hypoxemia and need for clinical measurement) and has an estimated estimate of 2%. DIAGNOSIS allows the detection of viral load in CRP-TR of patients with high clinical suspicion. TREATMENT based on supportive measures and infection control. In severe cases, the use of medications such as hydroxychloroquine and azithromycin or medication can be promising. Take care to avoid the use of corticosteroids. There are no restrictions on the use of resources and ACEIs / ARBs.
    Keywords coronavirus ; covid-19 ; sars-cov-2 ; pandemic ; update ; Medicine (General) ; R5-920 ; covid19
    Subject code 610
    Language English
    Publisher Associação Médica Brasileira
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top